<code id='4D4CB25CD7'></code><style id='4D4CB25CD7'></style>
    • <acronym id='4D4CB25CD7'></acronym>
      <center id='4D4CB25CD7'><center id='4D4CB25CD7'><tfoot id='4D4CB25CD7'></tfoot></center><abbr id='4D4CB25CD7'><dir id='4D4CB25CD7'><tfoot id='4D4CB25CD7'></tfoot><noframes id='4D4CB25CD7'>

    • <optgroup id='4D4CB25CD7'><strike id='4D4CB25CD7'><sup id='4D4CB25CD7'></sup></strike><code id='4D4CB25CD7'></code></optgroup>
        1. <b id='4D4CB25CD7'><label id='4D4CB25CD7'><select id='4D4CB25CD7'><dt id='4D4CB25CD7'><span id='4D4CB25CD7'></span></dt></select></label></b><u id='4D4CB25CD7'></u>
          <i id='4D4CB25CD7'><strike id='4D4CB25CD7'><tt id='4D4CB25CD7'><pre id='4D4CB25CD7'></pre></tt></strike></i>

          Home / knowledge / hotspot

          hotspot


          hotspot

          author:focus    Page View:9388
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In